|
|
CONTACT: Dr. John Gong, Managing Director, U.S. Operations; 301.540.5988 (o); AS THE 11TH AAALAC-CERTIFIED LAB IN CHINA, JOINN GLOBALLY POSITIONED AS GLP SERVICE PROVIDER GERMANTOWN, MD (November 1, 2008) – JOINN Laboratories has joined a rather exclusive club. The Beijing-based CRO has just been accredited by the Association for Assessment and Accreditation of Laboratory Animal Care(AAALAC), the world’s leading organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Gong said the certification signals 2008 as the year when Joinn, long a leading preclinical CRO in China, becomes a leading CRO in the world. (Only 11 of the world's 770 AAALAC-accredited organizations are in China.) “The [AAALAC] certification, along with our new DC-area office, fortifies our position in the international market,” he said. The certification comes four months after representatives of AAALAC inspected Joinn’s headquarters and research facility in southwest Beijing. The inspectors complimented the high quality of JOINN’s animal facilities, especially the state-of-the art housing rooms for non-human primates. JOINN is one of few preclinical CROs in the world to adopt pens especially designed for group-housing of NHPs. This simple step, which greatly raises NHPs' quality of life, helps puts JOINN among globally competitive CROs, Gong said. "The updating of our operations and certification of our labs come at a great moment," Gong said. "The modernity and quality of our animal facilities, combined with cost advantages of operating in China, will make us a very attractive option -- a nearly irresistible option -- over the coming years in the world marketplace for GLP research services." About JOINN: Founded in 1995 in Beijing, China, JOINN Laboratories is a contract research organization (CRO) offering comprehensive services in all areas of preclinical drug development, from the early stage drug discovery to the late stage regulatory toxicology studies. JOINN USA serves its international clients with their new drug development programs, including their regulatory and technical aspects. JOINN’s mission is to earn and keep customers by providing timely, high-quality services in preclinical contract research at reasonable cost. For more information, please visit joinnlaboratories.com |
